NCT04289987View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

February 19, 2020

Primary Completion Date

December 4, 2023

Study Completion Date

December 4, 2023

Conditions
Hepatitis B, Chronic
Interventions
BIOLOGICAL

CVI-HBV-002

Investigational Product

BIOLOGICAL

Normal Saline(placebo)

Investigational Product

Trial Locations (9)

13496

CHA University Bundang Medical Center, Seongnam-si

06973

Chung-ang University Hospital, Seoul

03312

The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul

06351

Samsung Medical Center, Seoul

08308

Korea University Guro Hospital, Seoul

03080

Seoul National University Hospital, Seoul

03722

Severance Hospital, Seoul

05505

Asan Medical Center, Seoul

04401

Soon Chung Hyang University Hospital Seoul, Seoul

All Listed Sponsors
lead

CHA Vaccine Institute Co., Ltd.

INDUSTRY

NCT04289987 - A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine | Biotech Hunter | Biotech Hunter